Cebrotonin Special Precautions

Caution is advised when this product is applied in case of patients with disturbed blood coagulation, major operations (including dental surgeries) or severe haemorrhages (e.g. gastric ulcer). Caution is also advised for patients who had an event in the past that affected the brain vessels and that was associated with a bleeding and patients who are taking medicines to prevent blood clotting or the aggregation of platelets (platelet aggregation), including low-dose acetylsalicylic acid. Patients with renal insufficiency should be supervised carefully as far as the rest-N- and creatinine-values are concerned.
In elderly patients who take Cebrotonin for a longer period, it is necessary that the physician regularly checks the values of creatinine clearance to adjust the dose if needed.
Patients who are taking medicines for seizures (anticonvulsants), should keep the treatment with anticonvulsants, even if they think their condition has improved since taking CEBROTONIN.
Doping Note: The use of CEBROTONIN 800 mg can lead to positive results in doping controls.
Hints regarding road traffic, operation of machines and works without secure hold: Due to observed adverse reactions a possible impairment of reactivity cannot be excluded. This should be bore in mind when driving a car or using machines.